Kyung Hee University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1949)

Organization Overview

First Clinical Trial
2006
NCT00967213
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

892 Dongnam-ro, Gangdong-gu, Seoul, Korea | 892 Dongnam-ro, Gangdong-gu, Seoul, Korea. Kyung Hee University Hospital at Gangdong | Chong-Jin Kim | Department of Internal Medicine, College of Oriental Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea | Department of Oriental Rehabilitation Medicine/College of Oriental Medicine/Kyung Hee University | Dept. of ophthalmology, KyungHee Medical Center | Dept. ophthalmology, Kyunghee medical center | Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital | Gangdong Kyunghee University Hospital | Kyung Hee East-West Neo Medical Center | Kyung Hee Oriental Medical Center | Kyunghee University | Kyung Hee University College of Medicine & Kyung Hee University Medical Center | Kyung-Hee University East-West Med. Center | Kyung Hee University Gangdong Hospital | KyungHee University Gangdong Hospital | Kyung Hee University Gangdong Hospital of Korea | Kyung Hee university Hosipital at Gangdong | Kyunghee University Hospital | Kyung Hee University Hospital | Kyunghee university hospital A Drug Analytical Laboratory | Kyunghee University Hospital at Gandong | Kyung Hee University Hospital at Gangdong | KyungHee University Hospital at Gangdong | Kyung Hee University Korean Medical Center | Kyunghee University Medical Center | Kyung Hee University Medical Center, Department of Pediatrics, | Kyung Hee University Medical Center Oriental Hospital | Kyung Hee University Medical Hospital | Kyunghee University Oriental Medical Center | Kyung Hee University Oriental Medicine Hospital | School of Medicine, Kyung Hee University | Seong-Gyu Ko | Spine Center, Kyung Hee University Hospital at Gangdong

Active Ingredients

Drugs in Phase 4 Trials (59)

5,7-dihydroxy-3',4',6-trimethoxyflavone (2 trials)

acetylsalicylic acid (aspirin) (3 trials)

alogliptin (nesina) (1 trial)

amino acids (Freamine) (1 trial)

amlodipine (norvasc) (4 trials)

amoxicillin (1 trial)

atomoxetine (strattera) (1 trial)

banhasasim-tang (1 trial)

betamethasone (celestone) (1 trial)

bevacizumab (avastin) (1 trial)

broccoli (1 trial)

celecoxib (celebrex) (3 trials)

cilostazol (pletal) (2 trials)

clarithromycin (biaxin) (2 trials)

clopidogrel (plavix) (5 trials)

danggui-sayuk-ga-osuyu-saenggang-tang (1 trial)

dapagliflozin (farxiga) (2 trials)

donepezil (aricept) (1 trial)

esomeprazole (nexium) (1 trial)

evogliptin (Suganon) (1 trial)

exenatide (byetta) (1 trial)

ezetimibe (zetia) (1 trial)

fentanyl (Innovar) (1 trial)

fluocinolone acetonide (synalar) (1 trial)

ginseng (3 trials)

glimepiride (amaryl) (3 trials)

hifenac (1 trial)

hydrochlorothiazide (esidrix) (3 trials)

hyeonggaeyeongyo-tang (1 trial)

immune globulin (human) (Gamastan) (1 trial)

insulin human (humulin) (1 trial)

ipragliflozin (sublet) (1 trial)

limaprost (1 trial)

losartan (cozaar) (2 trials)

midodrine (proamatine) (1 trial)

misoprostol (cytotec) (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

mycophenolate (CellCept) (1 trial)

naltrexone (revia) (1 trial)

nateglinide (starlix) (1 trial)

olmesartan (benicar) (2 trials)

onion peel extract (1 trial)

oxycodone (oxycontin) (1 trial)

pitavastatin (livalo) (1 trial)

polyethylene glycol (1 trial)

prednisone (meticorten) (1 trial)

pregabalin (lyrica) (1 trial)

quinapril (accupril) (1 trial)

ramosetron (2 trials)

ranibizumab (lucentis) (3 trials)

rebamipide (1 trial)

rosuvastatin (crestor) (2 trials)

sitagliptin (januvia) (3 trials)

sodium chloride (2 trials)

tacrolimus (prograf) (1 trial)

telmisartan (micardis) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

ticagrelor (brilinta) (4 trials)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (35)

ag npp709 (Synatura) (1 trial)

allogeneic adipose derived mesenchymal stem cell (6 trials)

asiasarum sieboldi f. maekawa (1 trial)

autologous culture chondrocytes (Carticel) (3 trials)

bosinji (2 trials)

carvedilol (coreg) (1 trial)

cinnamomum cassia (1 trial)

ckd-825 (1 trial)

dabigatran (pradaxa) (1 trial)

entecavir (baraclude) (1 trial)

ephedrine (1 trial)

euiiyin-tang (1 trial)

fenofibrate (fenoglide) (1 trial)

fimasartan (kanarb) (2 trials)

glycyrrhiza (1 trial)

iloperidone (fanapt) (1 trial)

inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)

levamlodipine (Conjupri) (1 trial)

lorazepam (ativan) (1 trial)

loxoprofen (3 trials)

maekmoondong-tang (1 trial)

melatonin (3 trials)

moxifloxacin (avelox) (1 trial)

ojeok-san (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

paeonia lactiflora (1 trial)

pinellia (1 trial)

pranlukast (Onon) (1 trial)

rivaroxaban (xarelto) (1 trial)

schisandra chinensis (1 trial)

sipjeondaebo-tang (2 trials)

umbilical cord mesenchymal stem cells (1 trial)

warfarin (coumadin) (1 trial)

zabofloxacin (1 trial)

Zingiber officinale (1 trial)

Drugs in Phase 2 Trials (21)

bee venom (3 trials)

belotecan (1 trial)

candesartan (atacand) (1 trial)

cellulose (1 trial)

cinnamon (1 trial)

cisplatin (platinol) (1 trial)

da-9801 (1 trial)

darbepoetin alfa (aranesp) (1 trial)

dienogest (natazia) (1 trial)

edoxaban (savaysa) (1 trial)

epoetin (Epogen) (1 trial)

ht047 (1 trial)

jaungo (1 trial)

methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)

paclitaxel (taxol) (1 trial)

pm012 (1 trial)

si000413 (1 trial)

sp-8203 (1 trial)

topotecan (hycamtin) (1 trial)

win34b (1 trial)

yh23537 (1 trial)

Drugs in Phase 1 Trials (3)

astrostem (1 trial)

docetaxel (taxotere) (1 trial)

sh003 (2 trials)

Drugs in Other Trials (14)

capecitabine (xeloda) (1 trial)

capsaicin (qutenza) (1 trial)

clonazepam (klonopin) (1 trial)

deciten (1 trial)

flecainide (tambocor) (1 trial)

glyburide (micronase) (1 trial)

gongjin-dan (1 trial)

Lactobacillus acidophilus (1 trial)

levofloxacin (levaquin) (1 trial)

lycium chinense (1 trial)

oxaliplatin (eloxatin) (1 trial)

rivastigmine (exelon) (1 trial)

seaweed (1 trial)

zaltoprofen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Angina, Stable (Phase 4)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 4)

Ascites (Phase 4)

Atrial Fibrillation (Phase 3)

Back Pain (Phase 2)

Behcet Syndrome (Phase 4)

Bronchitis (Phase 3)

Cerebral Infarction (Phase 2)

Cerebral Palsy (Phase 1)

Constriction, Pathologic (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Cough (Phase 3)

Crohn Disease (Phase 4)

Cryopyrin-Associated Periodic Syndromes (Phase 4)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 2)

Dyslipidemias (Phase 3)

Dyspepsia (Phase 4)

Eczema (Phase 2)

Edema (Phase 4)

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Endometriosis (Phase 2)

Essential Hypertension (Phase 3)

Gastritis (Phase 4)

Glomerulonephritis (Phase 3)

Glomerulonephritis, IGA (Phase 4)

Heart Diseases (Phase 4)

Hepatitis (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hernia (Phase 3)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hypersensitivity (Phase 4)

Hypertension (Phase 4)

Hypotension (Phase 4)

Hypotension, Orthostatic (Phase 4)

Infarction (Phase 4)

Infections (Phase 3)

Intermittent Claudication (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Low Back Pain (Phase 2)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 3)

Macular Degeneration (Phase 3)

Macular Edema (Phase 4)

Mucocutaneous Lymph Node Syndrome (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Nausea (Phase 4)

Neck Pain (Phase 2)

Neuralgia (Phase 2)

Nose Diseases (Phase 4)

Obesity (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overweight (Phase 4)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Prediabetic State (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Radiculopathy (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Reperfusion Injury (Phase 3)

Respiratory Tract Diseases (Phase 4)

Respiratory Tract Infections (Phase 3)

Retinal Vein Occlusion (Phase 3)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Sleep Initiation and Maintenance Disorders (Phase 3)

Small Cell Lung Carcinoma (Phase 2)

Spinal Stenosis (Phase 4)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

ST Elevation Myocardial Infarction (Phase 4)

Stroke (Phase 4)

Uterine Cervical Neoplasms (Phase 2)

Uveitis (Phase 4)

Ventricular Remodeling (Phase 4)

Vomiting (Phase 4)

Wet Macular Degeneration (Phase 3)

Wounds and Injuries (Phase 4)

Xerostomia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 116
  • # of Trial APIs: 132